Global Subcutaneous Drug Delivery Devices Market Report By Product (Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors, Needle-free Injectors), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214301
April 2021
Report Formats:
Global Subcutaneous Drug Delivery Devices Market Overview

The key driver impacting the subcutaneous drug delivery devices market is the growing prevalence of Cardiovascular Diseases (CVD) and diabetes with a surge in biological drug development. for instance, the World Health Organization reports, the cardiovascular diseases (CVDs) are considered as the number 1 cause of death worldwide and it affects 17.9 million lives every year. CVDs refer to the group of heart and blood vessel disorders and include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. as per the World Health Organization, in 2016, there are around 1.6 million deaths due to diabetes. according to the International Diabetic Federation (IDF), in 2019, approximately 463 million adults (20-79 years) were living with diabetes, and it is estimated to reach 700 million by 2045. Moreover, the high availability of advanced minimally invasive drug delivery such as auto-injectors, pen injectors, and prefilled syringes is estimated to be a significant factor contributing to market growth.
According to Value Market Research, the global subcutaneous drug delivery devices market size was valued at around USD 23500 million in 2020 and is estimated to grow at a CAGR of about 10% during the forecast period of 2021 to 2027.

The increasing adoption of subcutaneous drug delivery devices over intravenous administration due to its various advantages is estimated to augment subcutaneous drug delivery devices' demand in the forecast period—various benefits such as minimizing dosage errors and preventing needlestick injuries. also, higher treatment adherence is observed in patients with devices having easy drug administration protocols with no need for skilled personnel for drug administration, facilitate at-home drug delivery, and reduce patient time at healthcare facilities. however, the high cost of advanced delivery systems may hamper the global subcutaneous drug delivery devices market in the long run. also, the dearth of awareness in developing countries negatively impacts the market growth in the forecast period. the current industry trends, such as the rising trend of self-medication, expanding biosimilars market, and high production of biologics, are expected to provide market players with new market opportunities.

The subcutaneous drug delivery devices market is vast, with many local and global players. the key leaders follow different strategies to advance their market position, such as contracts, amalgamation, getting drug delivery devices license from regulatory authorities(FDA), extending product portfolio, acquisitions, and product upgrades to raise their market share across the globe. For instance, In June 2018, Insulet Corporation had received the U.S. FDA approval for the Omnipod DASH insulin management system. These digital platforms allow enhanced patient outcomes in diabetic patients. The major players in the report are Gerresheimer AG, Becton, Ypsomed AG, Becton, Novo Nordisk, Dickinson and Company, Elcam Medical Group, Medtronic Plc, Insulet Corporation, Becton, West Pharmaceutical Services, Inc., Inolife Sciences, PharmaJet, and Unilife Corporation.

Global Subcutaneous Drug Delivery Devices Market Share

In this research report, the subcutaneous drug delivery devices market is segmented by product, distribution channel, and region.

Analysis by Product:
By product type, the report is categorized into prefilled syringes, pen injectors, auto-injectors, wearable injectors, and needle-free injectors. The pen injectors segment dominates the product type segment with over 38% share in 2020. The high adoption of pen injectors due to the advantages it provides such as better patient satisfaction and adherence, superior ease of use, and greater dosing accuracy. Moreover, the growing product approvals, easy product design, affordability, and high social acceptance driving demand for pen injectors in the forecast period. 

Analysis by Distribution Channel:
By distribution channel, the report is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominates the distribution channel segment with over 45% share in 2020. It is due to the increasing self-administration, patient awareness, and growing focus on positive medical outcomes. Moreover, the manufacturers are launching programs to enable uninterrupted access to insulin for uninsured patients, contribute to the high market demand from distribution channels in the forecast period. 

Analysis by Region:
In the regional outlook of the global subcutaneous drug delivery devices market, the North America region dominates with a 44% market share during the forecast period. It is due to the high prevalence of chronic disease conditions such as multiple sclerosis, cardiovascular diseases, diabetes, and arthritis across the United States and Canada. Also, the developed healthcare infrastructure and the high adoption rate add growth to the subcutaneous drug delivery devices market. Moreover, the local presence of major players and continuous strategic initiatives implemented to maintain their market share with approval of drug delivery devices by the U.S. Food and Drugs Administration (FDA) contribute to the development of the subcutaneous drug delivery devices market in North America.

Market Segmentation covered in the Report:
By Product
  • Prefilled syringes
  • Pen injectors
  • Auto-injectors
  • Wearable injectors
  • Needle-free Injectors
 
By Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
 
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.  

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . SUBCUTANEOUS DRUG DELIVERY DEVICES – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product
           3.7.2 By Distribution Channel
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Prefilled syringes Market by Regions
       6.6 Pen injectors Market by Regions
       6.5 Auto-injectors Market by Regions
       6.7 Wearable injectors Market by Regions
       6.8 Needle-free Injectors Market by Regions
 
7 . GLOBAL SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Historical and Forecast Data
       7.3 Analysis by Distribution Channel
       7.4 Hospital pharmacies Market by Regions
       7.5 Retail pharmacies Market by Regions
       7.6 Online pharmacies Market by Regions
 
8 . GLOBAL SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE SUBCUTANEOUS DRUG DELIVERY DEVICES COMPANIES
       9.1. Subcutaneous Drug Delivery Devices Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF SUBCUTANEOUS DRUG DELIVERY DEVICES INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Gerresheimer AG
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Becton
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Ypsomed AG
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Becton
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Novo Nordisk
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Dickinson and Company
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Elcam Medical Group
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Medtronic Plc
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Insulet Corporation
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Becton
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. West Pharmaceutical Services, Inc.
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. Inolife Sciences
           10.14.1. Company Overview
           10.14.2. Financials
           10.14.3. Products
           10.14.4. Recent Developments
       10.15. PharmaJet
           10.15.1. Company Overview
           10.15.2. Financials
           10.15.3. Products
           10.15.4. Recent Developments
       10.16. Unilife Corporation
           10.16.1. Company Overview
           10.16.2. Financials
           10.16.3. Products
           10.16.4. Recent Developments
       10.17. 0
           10.17.1. Company Overview
           10.17.2. Financials
           10.17.3. Products
           10.17.4. Recent Developments
       10.18. 0
           10.18.1. Company Overview
           10.18.2. Financials
           10.18.3. Products
           10.18.4. Recent Developments
       10.19. COMPANY H
           10.19.1. Company Overview
           10.19.2. Financials
           10.19.3. Products
           10.19.4. Recent Developments
       10.20. COMPANY I
           10.20.1. Company Overview
           10.20.2. Financials
           10.20.3. Products
           10.20.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product (USD MN)
  •  Prefilled syringes Market by Geography (USD MN)
  •  Pen injectors Market by Geography (USD MN)
  •  Auto-injectors Market by Geography (USD MN)
  •  Wearable injectors Market by Geography (USD MN)
  •  Needle-free Injectors Market by Geography (USD MN)
  •  Analysis Market by Distribution Channel (USD MN)
  •  Hospital pharmacies Market by Geography (USD MN)
  •  Retail pharmacies Market by Geography (USD MN)
  •  Online pharmacies Market by Geography (USD MN)
  •  Global Subcutaneous Drug Delivery Devices Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Subcutaneous Drug Delivery Devices Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Subcutaneous Drug Delivery Devices Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product (USD MN)
  •  Prefilled syringes Market by Geography (USD MN)
  •  Pen injectors Market by Geography (USD MN)
  •  Auto-injectors Market by Geography (USD MN)
  •  Wearable injectors Market by Geography (USD MN)
  •  Needle-free Injectors Market by Geography (USD MN)
  •  Global Market Analysis by Distribution Channel (USD MN)
  •  Hospital pharmacies Market by Geography (USD MN)
  •  Retail pharmacies Market by Geography (USD MN)
  •  Online pharmacies Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials